Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil combined with propofol for fiberoptic bronchoscopy
ChiCTR2100042521Phase 4Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Feb 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alfentanil, propofol, fentanyl, remifentanil and sufentanil (4 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoint: Cough reaction. Started Feb 2021; status: recruiting.
02
Drugs
alfentanilpropofolfentanylremifentanilsufentanil
Beyond the preview
Go deeper on ChiCTR2100042521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042521.